News

We will attend the digital Sachs Associates 14th European Life Sciences CEO Forum on 10-11 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.

Immunetune is proud to announce that they can continue their regulatory pathway, following supportive Scientific Advice from the Paul-Ehrlich Institute (PEI) in Germany on the 18th of June 2020. “The overall positive feedback received from the renowned...

Roger Legtenberg, CBO of Immunetune, will attend the Biotechgate Digital Partnering event on 31 Aug - 3 Sep, 2020. Feel free to request a meeting if you’d like to hear more about possible partnering or investment...

Immunetune is proud to announce that they can continue their regulatory pathway, following supportive Scientific Advice from the Paul-Ehrlich Institute (PEI) in Germany on the 18th of June 2020. “The overall positive feedback received from the renowned...

Roger Legtenberg, CBO of Immunetune, will attend the Biotechgate Digital Partnering event on 31 Aug - 3 Sep, 2020. Feel free to request a meeting if you’d like to hear more about possible partnering or investment...

Within a newly established consortium, Immunetune will develop enhanced DNA vaccines against SARS-CoV-2 and other human coronaviruses. The vaccine is built on the combination of two strong synthetic vaccine platforms and the inclusion of conserved T and B cell...

We're proud to be featured as one of the 200 companies in the overview: #DutchTechHeroes Fighting COVID-19. It is more important than ever that we empower & accelerate the tech companies that help us fight this pandemic. Find out more here by @TechLeapNL.